U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H25NO3
Molecular Weight 291.3853
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUNOLOL

SMILES

CC(C)(C)NCC(O)COC1=CC=CC2=C1CCCC2=O

InChI

InChIKey=IXHBTMCLRNMKHZ-UHFFFAOYSA-N
InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C17H25NO3
Molecular Weight 291.3853
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Bunolol is non-selective beta-adrenoreceptor antagonist with significant antihypertensive, antiarrhythmic and local anesthetic activities. Bunolol is a racemic mixture and Levobunolol is greater than 60 times more potent than its dextro isomer in its beta-blocking activity. Bunolol is 3 times as potent as propranolol by i.v. administration in anesthetized dogs in antagonizing the cardiovascular actions of isoproterenol and the response to cardioaccelerans nerve stimulation. When oral doses were given to unanesthetized dogs with subsequent induction of anesthesia, Bunolol was 20 times as potent as propranolol. The β-adrenergic blocking activity of Bunolol appeared to be competitive, and the activity was largely restricted to the l-isomer. Bunolol is extensively metabolized by both oxidative and reductive routes.

Originator

Sources: Journal of Pharmacology and Experimental Therapeutics (1970), 175, (1), 157-67

Approval Year

PubMed

PubMed

TitleDatePubMed
Ocular Metabolism of Levobunolol: Historic and Emerging Metabolic Pathways.
2016 Aug
Patents

Patents

Substance Class Chemical
Created
by admin
on Fri Dec 15 17:20:11 GMT 2023
Edited
by admin
on Fri Dec 15 17:20:11 GMT 2023
Record UNII
71QSY2UT3G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUNOLOL
INN   MART.  
INN  
Official Name English
BUNOLOL [MART.]
Common Name English
1(2H)-NAPHTHALENONE, 5-(3-(1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPOXY)-3,4-DIHYDRO-, (±)-
Common Name English
(±)-5-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)-3,4-DIHYDRO-1(2H)-NAPHTHALENONE
Systematic Name English
bunolol [INN]
Common Name English
Code System Code Type Description
FDA UNII
71QSY2UT3G
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
NCI_THESAURUS
C166977
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
ChEMBL
CHEMBL293030
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
CHEBI
58612
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
EVMPD
SUB05979MIG
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
PUBCHEM
3914
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
CHEBI
29110
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
CAS
26718-17-2
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
SUPERSEDED
INN
2762
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
CAS
27591-01-1
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
EPA CompTox
DTXSID7022702
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
SMS_ID
100000088447
Created by admin on Fri Dec 15 17:20:11 GMT 2023 , Edited by admin on Fri Dec 15 17:20:11 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY